HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Downregulation of long non‑coding RNA UCA1 enhances the radiosensitivity and inhibits migration via suppression of epithelial‑mesenchymal transition in colorectal cancer cells.

Abstract
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and common cause of cancer‑related deaths. Radiotherapy has become a routine treatment for CRC. However, radioresistance affects therapeutic efficacy. Long non‑coding RNA urothelial carcinoma associated 1 (UCA1) has been demonstrated to be overexpressed in several tumors and predicts a poor prognosis. In the present study, we revealed that lncRNA‑UCA1 was overexpressed in colorectal cancer tissue and colon cancer cells when compared to normal tissue and cells. Quantitative real‑time PCR revealed that the expression of UCA1 was significantly higher in CRC tissues after chemoradiotherapy. Downregulation of UCA1 enhanced the radiosensitivity of CCL244 cells via inhibition of the colony formation, proliferation and promotion of radiation‑induced apoptosis and G2/M arrest. Moreover, downregulation of UCA1 suppressed the epithelial‑mesenchymal transition (EMT) in CCL244 cells.
AuthorsXiaodong Yang, Wei Liu, Xiaohui Xu, Junjia Zhu, Yong Wu, Kui Zhao, Songbin He, Ming Li, Yongyou Wu, Shuyu Zhang, Jianping Cao, Zhenyu Ye, Chungen Xing
JournalOncology reports (Oncol Rep) Vol. 40 Issue 3 Pg. 1554-1564 (Sep 2018) ISSN: 1791-2431 [Electronic] Greece
PMID30015983 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • RNA, Long Noncoding
  • UCA1 RNA, human
Topics
  • Aged
  • Apoptosis
  • Biomarkers, Tumor (genetics)
  • Case-Control Studies
  • Cell Movement
  • Cell Proliferation
  • Colorectal Neoplasms (genetics, pathology, radiotherapy)
  • Epithelial-Mesenchymal Transition (genetics)
  • Female
  • Follow-Up Studies
  • Gene Expression Regulation, Neoplastic (radiation effects)
  • Humans
  • Lymphatic Metastasis
  • Male
  • Neoplasm Invasiveness
  • Prognosis
  • RNA, Long Noncoding (genetics)
  • Radiation Tolerance (genetics)
  • Tumor Cells, Cultured
  • Wound Healing
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: